ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

13,628Medicare Part D Prescriptions Filled, Including Refills

Rank: 160 out of 682

$749K Total Retail Price of All Prescriptions

Rank: 172 out of 682

630 Patients Receiving at Least One Drug in Part D
82%Patients 65 Years and Older
42% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kentucky
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 630 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

24% of this provider’s 630 patients filled at least one prescription for a schedule three drug, compared to an average of 17%.

Risky Drugs to Seniors

3% of this provider’s 10,682 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 24.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kentucky
LISINOPRIL 688 580 1 2
HYDROCODONE-ACETAMINOPHEN 686 447 S3 2 1
OMEPRAZOLE 494 360 3 5
LEVOTHYROXINE SODIUM 462 394 4 3
METFORMIN HCL 386 331 5 8
FUROSEMIDE 356 303 6 7
GABAPENTIN 342 267 7 9
HYDROCHLOROTHIAZIDE 325 234 8 12
CARVEDILOL 310 273 9 23
SIMVASTATIN 309 241 10 4
WARFARIN SODIUM 247 187 11 13
ZOLPIDEM TARTRATE 225 157 12 21
AMLODIPINE BESYLATE 220 189 13 6
PRAVASTATIN SODIUM 196 166 14 15
METOPROLOL TARTRATE 189 127 15 10
CYMBALTA 168 122 16 51
CITALOPRAM HBR 152 97 17 17
TRAMADOL HCL 149 123 18 26
POTASSIUM CHLORIDE 140 132 19 14
SERTRALINE HCL 140 102 19 24
LOSARTAN POTASSIUM 140 105 19 20
TAMSULOSIN HCL 135 116 22 33
ATENOLOL 129 121 23 18
DIOVAN 115 93 24 42
GLYBURIDE 113 73 R 25 72
LORAZEPAM 113 109 25 158
METOPROLOL SUCCINATE 112 93 27 16
ATORVASTATIN CALCIUM 108 78 28 11
OXYCODONE HCL 105 55 S2 29 93
DIGOXIN 102 88 30 46
PREDNISONE 92 76 31 40
LISINOPRIL-HYDROCHLOROTHIAZIDE 90 75 32 34
GEMFIBROZIL 90 63 32 122
CELEBREX 89 69 34 80
ALLOPURINOL 89 75 34 32
TORSEMIDE 88 71 36 155
MIRTAZAPINE 86 67 37 52
TRIAMTERENE-HCTZ 84 73 38 57
AZITHROMYCIN 78 65 39 39
ENDOCET 77 50 S2 40 88
POLYETHYLENE GLYCOL 3350 75 67 41 44
CLONIDINE HCL 75 68 41 48
TRICOR 73 60 43 94
OXYCODONE HCL-ACETAMINOPHEN 71 45 S2 44 98
FLUTICASONE PROPIONATE 71 58 44 36
CYCLOBENZAPRINE HCL 68 36 R 46 65
PROMETHAZINE HCL 67 34 R 47 54
NEXIUM 67 65 47 19
TEKTURNA 63 62 49 243
ADVAIR DISKUS 62 56 50 47
NAMENDA 60 53 51 41
LANTUS SOLOSTAR 60 37 51 114
ISOSORBIDE MONONITRATE ER 60 58 51 31
DOXAZOSIN MESYLATE 58 58 54 96
LEVOFLOXACIN 58 52 54 70
METFORMIN HCL ER 55 40 56 68
DIOVAN HCT 55 37 56 109
ZETIA 54 38 58 69
LIDODERM 53 37 59 134
ESCITALOPRAM OXALATE 53 43 59 73
ESTRADIOL 52 23 R 61 152
MELOXICAM 52 49 61 27
CLOPIDOGREL 51 42 63 25
CRESTOR 51 40 63 22
KLOR-CON M20 51 34 63 67
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 10, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.